Literature DB >> 17108690

Histological and immunohistological changes of the skeletal muscles in older SJL/J mice.

Hiroshi Nemoto1, Shingo Konno, Hiroshi Nakazora, Hiroko Miura, Teruyuki Kurihara.   

Abstract

SJL/J mice have been studied as the model animals for autoimmunological diseases. Recently it was clarified that SJL/J mice have a defect of dysferlin. Human limb girdle muscular dystrophy 2B and Miyoshi myopathy also have a defect of dysferlin. In this study we present the histological and immunohistological changes in the natural course. Histological study revealed that SJL/J mice had inflammatory, degenerative changes, and neurogenic changes in later ages. As for interstitial inflammatory cells, the macrophages were dominant in any age, and in the T cell subset, the CD4+ T cells were more abundant than the CD8+ T cells, and few B cells were seen. The laboratory data showed a high level of creatine kinase in all ages. It is suspected that the inflammatory changes were induced by the primary immunological abnormality or by the defect of dysferlin in SJL/J mice. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108690     DOI: 10.1159/000097005

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  7 in total

Review 1.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

2.  Annexin A2 links poor myofiber repair with inflammation and adipogenic replacement of the injured muscle.

Authors:  Aurelia Defour; Sushma Medikayala; Jack H Van der Meulen; Marshall W Hogarth; Nicholas Holdreith; Apostolos Malatras; William Duddy; Jessica Boehler; Kanneboyina Nagaraju; Jyoti K Jaiswal
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 6.150

3.  Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice.

Authors:  Renzhi Han; Ellie M Frett; Jennifer R Levy; Erik P Rader; John D Lueck; Dimple Bansal; Steven A Moore; Rainer Ng; Daniel Beltrán-Valero de Bernabé; John A Faulkner; Kevin P Campbell
Journal:  J Clin Invest       Date:  2010-11-08       Impact factor: 14.808

4.  Assessment of disease activity in muscular dystrophies by noninvasive imaging.

Authors:  Katie K Maguire; Leland Lim; Sedona Speedy; Thomas A Rando
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

5.  Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype.

Authors:  Sree Rayavarapu; Jack H Van der Meulen; Heather Gordish-Dressman; Eric P Hoffman; Kanneboyina Nagaraju; Susan M Knoblach
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

6.  Literature-aided meta-analysis of microarray data: a compendium study on muscle development and disease.

Authors:  Rob Jelier; Peter A C 't Hoen; Ellen Sterrenburg; Johan T den Dunnen; Gert-Jan B van Ommen; Jan A Kors; Barend Mons
Journal:  BMC Bioinformatics       Date:  2008-06-24       Impact factor: 3.169

7.  Genetic silencing of Nrf2 enhances X-ROS in dysferlin-deficient muscle.

Authors:  Ponvijay Kombairaju; Jaclyn P Kerr; Joseph A Roche; Stephen J P Pratt; Richard M Lovering; Thomas E Sussan; Jung-Hyun Kim; Guoli Shi; Shyam Biswal; Christopher W Ward
Journal:  Front Physiol       Date:  2014-02-19       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.